|
Volumn 58, Issue 548, 2008, Pages 208-209
|
Complementary and alternative medicine: What the NHS should be funding?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AESCULUS HIPPOCASTANUM EXTRACT;
CRATAEGUS EXTRACT;
GINKGO BILOBA EXTRACT;
GUAR GUM;
HERBACEOUS AGENT;
HYPERICUM PERFORATUM EXTRACT;
KAVA EXTRACT;
MELATONIN;
PADMA 28;
PHYTODOLOR;
PYGEUM AFRICANUM EXTRACT;
RED CLOVER EXTRACT;
S ADENOSYLMETHIONINE;
SABAL EXTRACT;
UBIDECARENONE;
UNCLASSIFIED DRUG;
ACUPUNCTURE;
ALTERNATIVE MEDICINE;
ALZHEIMER DISEASE;
ANXIETY DISORDER;
AROMATHERAPY;
ARTERY DISEASE;
ARTICLE;
CANCER PALLIATIVE THERAPY;
CHRONIC VEIN INSUFFICIENCY;
CLINICAL EFFECTIVENESS;
CONGESTIVE HEART FAILURE;
CONSENSUS DEVELOPMENT;
COST EFFECTIVENESS ANALYSIS;
DEPRESSION;
DIABETES MELLITUS;
EVIDENCE BASED PRACTICE;
FINANCIAL MANAGEMENT;
HOMEOPATHY;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
HYPNOSIS;
INSOMNIA;
INTERMETHOD COMPARISON;
LABOR PAIN;
MASSAGE;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MENOPAUSAL SYNDROME;
MUSIC THERAPY;
NATIONAL HEALTH SERVICE;
NAUSEA AND VOMITING;
OSTEOARTHRITIS;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PROSTATE HYPERTROPHY;
RELAXATION TRAINING;
RHEUMATIC DISEASE;
RISK BENEFIT ANALYSIS;
SOYBEAN;
TREATMENT CONTRAINDICATION;
UNITED KINGDOM;
COMPLEMENTARY THERAPIES;
COST-BENEFIT ANALYSIS;
FINANCING, ORGANIZED;
GREAT BRITAIN;
HUMANS;
STATE MEDICINE;
|
EID: 40749119709
PISSN: 09601643
EISSN: None
Source Type: Journal
DOI: 10.3399/bjgp08X279562 Document Type: Article |
Times cited : (15)
|
References (14)
|